Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOCK HFpEF
NCT04434664Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Dec 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amlodipine, metoprolol in heart failure with preserved ejection fraction (HFpEF), hypertension (HTN), sponsored by University of Pennsylvania. Started Dec 2021; status: completed.
02
Drugs
amlodipinemetoprolol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)hypertension (HTN)
Beyond the preview
Go deeper on NCT04434664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434664.